... in Taiwan and Hong Kong have been given permission
to sue a multi-national drugs firm in the US over allegations that
they contracted HIV from contaminated blood products that the
company knowingly ...
... the world’s leading health problems are likely to be resolved by the development of clever new drugs. However these will have little relevance if there is no system in place to deliver them,” said ...
The German health care company Fresenius said it had agreed to buy the American generic drug maker APP Pharmaceuticals for $3.7 billion.
The Chinese manufacturer of a ginseng injection that killed three people has recalled all its injection products, the country's drug safety watchdog said Saturday.
BRUSSELS, Nov. 28 (UPI) -- The European Commission has accused drug companies of blocking the entry of cheaper generic drugs into Europe, adding billions to the cost of medicine.
... side effects of direct to consumer advertising. For instance, the profile of profitable branded drugs may be increased, which will increase spending on prescription medicines by patients and the NHS. ...
Drug firms announce advances in personalized medicine at oncologists' meeting.
Dick Armey, a former Republican House leader, resigned from his lobbying firm after drug company clients complained about his opposition to the Obama health plan.
Acquisition expands drug firm's specialty product lines in the U.S.
The American drug maker Sepracor accepted an offer of $2.6 billion from Dainippon, which wants more products and overseas sales.
China, battling to restore trust in its products, has closed a pharmaceutical company whose herbal injections have been linked to three deaths.
Critics say drug firms worked to discredit a clinical trial that found that inexpensive pills for hypertension worked better than newer drugs.
Doctors debate new cancer treatment... Northwestern U. opens obesity clinic... Gene flap delays babies' epilepsy care... EU says drug firms blocked generics... Health/Science news from UPI.
Indian drug firm may earn up to $300 million in multi-year partnership.
